Follow the latest coverage, related explainers and connected technology stories.
Results from the FlexPulse IDE study showed that Abbott’s TactiFlex Duo catheter, which combines pulsed-field ablation and radiofrequency ablation, achieved efficacy and safety after one year of treating patients with paroxysmal atrial fibrillation. The company plans to use the data as the basis for submitting an application to the FDA to market the catheter in the United States.